What influences men's decision to have a prostate-specific antigen test? A qualitative study

Family Practice

Volumn 24, Issue 4, 2007, Pages 365-371

  Rai, Tanvi ^a   Clements, Alison ^a   Bukach, Colleen ^a   Shine, Brian ^b   Austoker, Joan ^a   Watson, Eila ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Decision making; Patient information; Prostate cancer screening; Prostate specific antigen; Qualitative research

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCESS TO INFORMATION; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; CLINICAL ARTICLE; CONSULTATION; DECISION MAKING; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; FAMILY HISTORY; GENERAL PRACTITIONER; HEALTH BELIEF; HEALTH PROMOTION; HUMAN; INFORMATION DISSEMINATION; MALE; MASS MEDIUM; PROSTATE CANCER; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; URINARY TRACT DISEASE;

AGED; DECISION MAKING; ENGLAND; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 34548645664     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmm033     Document Type: Article

References (21)

1. UK National Screening Committee. Second Report of the UK National Screening Committee. London: Department of Health, 2000.
2. de Koning HJ, Auvinen A, Berenguer SA et al. Large-scale randomized prostate cancer screening trials: Program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237-244.
3. National Screening Committee. Prostate Cancer Risk Management Programme. August 2001 (Version 2). http://www.nelc.org.uk/docs/risk/ risk.htm (last accessed 18 February 2002).
4. Watson E, Jenkins L, Bukach C, Brett J, Austoker J. Prostate Cancer Risk Management Programme: An Information Pack for Primary Care. Sheffield, UK: NHS Cancer Screening Programmes, 2002.
5. Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract symptoms in men aged 45-79 years: A population-based study of 40000 Swedish men. BJU Int 2004; 94 327-331.
6. Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int 2000; 85: 1037-1048.
7. Hamilton W, Sharp DJ, Peters TJ, Round AP. Clinical features of prostate cancer before diagnosis: A population-based, case-control study. Br J Gen Pract 2006; 56: 756-762.
8. Watson E, Hewitson P, Brett J et al. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: A randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested. Patient Educ Couns 2006; 63: 367-379.
9. Gattellari M, Ward JE. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen 2003; 10: 27-39.
10. Partin MR, Nelson D, Radosevich D et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med 2004; 19: 835-842.
11. Schapira MM, Van Ruiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract 2000; 49: 418-424.
12. Hewitson P, Austoker J. Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. BJU Int 2005; 95(suppl 3): 16-32.
13. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med 1999; 8: 333-340.
14. Sheridan SL, Felix K. Pignone MP, Lewis CL. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid. Patient Educ Couns 2004; 54: 345-351.
15. O'Connor AM, Stacey D, Entwistle V et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003; CD001431.
16. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In Bryman A, Burgess R (eds). Analysing Qualitative Data London: Routledge, 1993: 173-194.
17. Farrell MH, Murphy MA, Schneider CE. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing. Eff Clin Pract 2002; 5: 120-129.
18. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Cancer 2006; 107: 620-630.
19. Chamot E, Charvet AI, Perneger TV. Variability in women's desire for information about mammography screening: Implications for informed consent. Eur J Cancer Prev 2005; 14: 413-418.
20. Katz ML, Sheridan S, Pignone M et al. Prostate and colon cancer screening messages in popular magazines. J Gen Intern Med 2004; 19: 843-848.
21. Irwig L, McCaffery K, Salkeld G, Bossuyt P. Informed choice for screening: Implications for evaluation. Br Med J 2006; 332: 1148-1150.